Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Nature Communications|July 15, 2021
Single-cell microRNA sequencing method comparison and application to cell lines and circulating lung tumor cellsSarah M Hücker, Tobias Fehlmann, Christian Werno, et al.
BMJ Open|January 7, 2022
Association between initial opioid prescription diagnosis type and subsequent chronic prescription opioid use in Rhode Island: a population-based cohort studyBenjamin D Hallowell, Laura C Chambers, Luke Barre, et al.
International Journal of Cancer|December 27, 2018
Microfluidic enrichment, isolation and characterization of disseminated melanoma cells from lymph node samplesKathrin Weidele, Nataša Stojanović, Giancarlo Feliciello, et al.
Journal of Addiction Medicine|April 25, 2025
Bystander Presence and Naloxone Administration During Fatal Opioid-involved Overdoses in Rhode Island: Implications for Naloxone Coverage Among Families and PeersLila Flavin, Joseph G Rosen, Kristen St John, et al.
International Journal of Cancer|August 9, 2023
Ex vivo expansion of lung cancer-derived disseminated cancer cells from lymph nodes identifies cells associated with metastatic progressionSteffi Treitschke, Kathrin Weidele, Adithi Ravikumar Varadarajan, et al.
Nature Communications|February 11, 2018
Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanomaMelanie Werner-Klein, Sebastian Scheitler, Martin Hoffmann, et al.
EMBO Molecular Medicine|December 5, 2025
Micrometastasis-derived models enable drug testing for early-stage, high-risk melanoma patientsKathrin Weidele, Christian Werno, Steffi Treitschke, et al.
Nature Cancer|May 16, 2025
MCSP<sup>+</sup> metastasis founder cells activate immunosuppression early in human melanoma metastatic colonizationSeverin Guetter, Courtney König, Huiqin Koerkel-Qu, et al.
Nature Communications|October 6, 2020
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latencyMelanie Werner-Klein, Ana Grujovic, Christoph Irlbeck, et al.
Molecular Oncology|October 5, 2024
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patientsNataša Stojanović Gužvić, Florian Lüke, Steffi Treitschke, et al.
Pageof 3